Showing 7,281 - 7,300 results of 10,354 for search '(( significant processes decrease ) OR ( significant ((we decrease) OR (mean decrease)) ))', query time: 0.64s Refine Results
  1. 7281

    Data Sheet 1_In vivo profiling of the PE/PPE proteins of Mycobacterium tuberculosis reveals diverse contributions to virulence.pdf by Benjamin Koleske (11581641)

    Published 2025
    “…We found consistent, time-dependent changes in mutant abundance across our animal replicates and identified decreases in several key mutant strains known to promote bacterial growth or virulence. …”
  2. 7282

    Table 1_Revealing fitness and virulence determinants of hypervirulent Klebsiella pneumoniae during infection in Galleria mellonella using a transposon library.xlsx by Lisheng Xiao (15919517)

    Published 2025
    “…Going beyond the general knowledge that hypermucoviscosity (HMV) mediates high virulence, we observed that deficits in ptsI and GM2628 led to HMV while decreasing virulence. …”
  3. 7283

    Exploring the effects of COVID-19 on verbal memory function in schizophrenia: Multiple case study and brief literature review by Barbora Keřková (15125926)

    Published 2024
    “…We calculated the Reliable Change Index to estimate the clinical significance of verbal memory performance changes, with annualized change rates in hippocampal volumes assessed against normative data. …”
  4. 7284

    Table 1_In vivo profiling of the PE/PPE proteins of Mycobacterium tuberculosis reveals diverse contributions to virulence.xlsx by Benjamin Koleske (11581641)

    Published 2025
    “…We found consistent, time-dependent changes in mutant abundance across our animal replicates and identified decreases in several key mutant strains known to promote bacterial growth or virulence. …”
  5. 7285

    Supplementary Material for: Supportive care for common conditions in small vulnerable newborns and term infants: the evidence by Jiang L. (4145290)

    Published 2025
    “…Method Following a comprehensive literature scope, we updated or re-analyzed LMIC-specific evidence for essential SVN care interventions. …”
  6. 7286

    Data Sheet 1_Revealing fitness and virulence determinants of hypervirulent Klebsiella pneumoniae during infection in Galleria mellonella using a transposon library.pdf by Lisheng Xiao (15919517)

    Published 2025
    “…Going beyond the general knowledge that hypermucoviscosity (HMV) mediates high virulence, we observed that deficits in ptsI and GM2628 led to HMV while decreasing virulence. …”
  7. 7287

    Video1_The immunomodulatory impact of naturally derived neem leaf glycoprotein on the initiation progression model of 4NQO induced murine oral carcinogenesis: a preclinical study.m... by Juhina Das (17808068)

    Published 2024
    “…Flow-cytometric evidences suggest that NLGP treatment upregulated CD8<sup>+</sup>, IFNγ<sup>+</sup>, granzyme B<sup>+</sup>, CD11c<sup>+</sup> cells in comparison to 4NQO treated mice with a decrease in Ki67<sup>+</sup> and CD4<sup>+</sup>FoxP3<sup>+</sup> cells in NLGP treated cohort. …”
  8. 7288

    DataSheet2_The immunomodulatory impact of naturally derived neem leaf glycoprotein on the initiation progression model of 4NQO induced murine oral carcinogenesis: a preclinical stu... by Juhina Das (17808068)

    Published 2024
    “…Flow-cytometric evidences suggest that NLGP treatment upregulated CD8<sup>+</sup>, IFNγ<sup>+</sup>, granzyme B<sup>+</sup>, CD11c<sup>+</sup> cells in comparison to 4NQO treated mice with a decrease in Ki67<sup>+</sup> and CD4<sup>+</sup>FoxP3<sup>+</sup> cells in NLGP treated cohort. …”
  9. 7289

    DataSheet1_The immunomodulatory impact of naturally derived neem leaf glycoprotein on the initiation progression model of 4NQO induced murine oral carcinogenesis: a preclinical stu... by Juhina Das (17808068)

    Published 2024
    “…Flow-cytometric evidences suggest that NLGP treatment upregulated CD8<sup>+</sup>, IFNγ<sup>+</sup>, granzyme B<sup>+</sup>, CD11c<sup>+</sup> cells in comparison to 4NQO treated mice with a decrease in Ki67<sup>+</sup> and CD4<sup>+</sup>FoxP3<sup>+</sup> cells in NLGP treated cohort. …”
  10. 7290

    Table 1_Efficacy and safety of levetiracetam in preventing postoperative seizures in adult patients with brain tumors: a meta-analysis.docx by Yongyi Zhang (1800337)

    Published 2025
    “…</p>Review methods<p>We gathered studies comparing the effectiveness of levetiracetam with other antiepileptic drugs in preventing postoperative seizures in individuals with brain tumor from 2008 to 2023. …”
  11. 7291

    Table 2_Efficacy and safety of levetiracetam in preventing postoperative seizures in adult patients with brain tumors: a meta-analysis.docx by Yongyi Zhang (1800337)

    Published 2025
    “…</p>Review methods<p>We gathered studies comparing the effectiveness of levetiracetam with other antiepileptic drugs in preventing postoperative seizures in individuals with brain tumor from 2008 to 2023. …”
  12. 7292

    Image 3_Efficacy and safety of levetiracetam in preventing postoperative seizures in adult patients with brain tumors: a meta-analysis.jpeg by Yongyi Zhang (1800337)

    Published 2025
    “…</p>Review methods<p>We gathered studies comparing the effectiveness of levetiracetam with other antiepileptic drugs in preventing postoperative seizures in individuals with brain tumor from 2008 to 2023. …”
  13. 7293

    Image 1_Efficacy and safety of levetiracetam in preventing postoperative seizures in adult patients with brain tumors: a meta-analysis.tif by Yongyi Zhang (1800337)

    Published 2025
    “…</p>Review methods<p>We gathered studies comparing the effectiveness of levetiracetam with other antiepileptic drugs in preventing postoperative seizures in individuals with brain tumor from 2008 to 2023. …”
  14. 7294

    Image 2_Efficacy and safety of levetiracetam in preventing postoperative seizures in adult patients with brain tumors: a meta-analysis.tif by Yongyi Zhang (1800337)

    Published 2025
    “…</p>Review methods<p>We gathered studies comparing the effectiveness of levetiracetam with other antiepileptic drugs in preventing postoperative seizures in individuals with brain tumor from 2008 to 2023. …”
  15. 7295

    Image 4_Efficacy and safety of levetiracetam in preventing postoperative seizures in adult patients with brain tumors: a meta-analysis.tif by Yongyi Zhang (1800337)

    Published 2025
    “…</p>Review methods<p>We gathered studies comparing the effectiveness of levetiracetam with other antiepileptic drugs in preventing postoperative seizures in individuals with brain tumor from 2008 to 2023. …”
  16. 7296

    Table 2_Impact of chemoradiotherapy for first primary lung cancer on the prognosis and re-chemoradiotherapy sensitivity of second primary lung cancer.docx by Zhe Chen (196097)

    Published 2025
    “…Among these, 5,302 FPLC patients developed SPLC within 5 years of their initial diagnosis. We employed the Fine-Gray competitive risk model, Cox proportional hazards model, and restricted mean survival time analysis to assess the effects of FPLC radiotherapy and chemotherapy on SPLC risk and survival differences.…”
  17. 7297

    Data Sheet 1_Impact of chemoradiotherapy for first primary lung cancer on the prognosis and re-chemoradiotherapy sensitivity of second primary lung cancer.xlsx by Zhe Chen (196097)

    Published 2025
    “…Among these, 5,302 FPLC patients developed SPLC within 5 years of their initial diagnosis. We employed the Fine-Gray competitive risk model, Cox proportional hazards model, and restricted mean survival time analysis to assess the effects of FPLC radiotherapy and chemotherapy on SPLC risk and survival differences.…”
  18. 7298

    Table 3_Impact of chemoradiotherapy for first primary lung cancer on the prognosis and re-chemoradiotherapy sensitivity of second primary lung cancer.docx by Zhe Chen (196097)

    Published 2025
    “…Among these, 5,302 FPLC patients developed SPLC within 5 years of their initial diagnosis. We employed the Fine-Gray competitive risk model, Cox proportional hazards model, and restricted mean survival time analysis to assess the effects of FPLC radiotherapy and chemotherapy on SPLC risk and survival differences.…”
  19. 7299

    Table 1_Impact of chemoradiotherapy for first primary lung cancer on the prognosis and re-chemoradiotherapy sensitivity of second primary lung cancer.docx by Zhe Chen (196097)

    Published 2025
    “…Among these, 5,302 FPLC patients developed SPLC within 5 years of their initial diagnosis. We employed the Fine-Gray competitive risk model, Cox proportional hazards model, and restricted mean survival time analysis to assess the effects of FPLC radiotherapy and chemotherapy on SPLC risk and survival differences.…”
  20. 7300

    Data Sheet 1_Sex differences in the reactivity of gastric myoelectrical activity and heart rate variability as putative psychophysiological markers in human pain research.docx by Rossitza Draganova (9154951)

    Published 2024
    “…</p>Results<p>Acute pain induced significant instability in EGG slow-wave frequency and amplitude, increased tachygastria, and decreased normogastric spectral power, without evidence of sex differences. …”